Parasacral transcutaneous electrical neural stimulation (PTENS) once a week for the treatment of overactive bladder

Lidyanne Ilidia da Silva de Paula1, Liliana Fajardo de Oliveira1, Brysa Paiva Cruz1

  • 1Division of Urology, Department of Surgery, Federal University of Juiz de Fora (UFJF), MG, Brazil.

Insights

Parasacral Transcutaneous Electrical Neural Stimulation (PTENS) in weekly sessions effectively treated overactive bladder (OAB) symptoms like urgency and enuresis in children. Caregiver perception of improvement was also noted.

Area of Science:

  • Pediatric Urology
  • Neurology

Background:

  • Overactive bladder (OAB) is a common childhood voiding disorder, primarily causing urinary urgency.
  • Current treatments like urotherapy and anticholinergics have limitations in adherence.
  • Parasacral Transcutaneous Electrical Neural Stimulation (PTENS) offers an alternative, but previous protocols were intensive.

Purpose of the Study:

  • To evaluate the efficacy of PTENS administered in single weekly sessions for treating OAB in children.
  • To assess adherence and symptom improvement with a less intensive PTENS protocol.

Main Methods:

  • A prospective, randomized controlled trial involved 16 children with OAB, divided into a control group (urotherapy + placebo stimulation) and an experimental group (urotherapy + PTENS).
  • Both groups received 20 weekly 20-minute sessions.
  • Outcomes were measured using voiding diaries, visual analogue scale (VAS), Rome III criteria, and Bristol Scale at baseline, post-treatment, and 60 days later.

Main Results:

  • The PTENS group showed significant improvement in urinary urgency (p=0.03) and an increase in dry nights (p=0.03) 60 days post-treatment.
  • Caregivers reported greater symptom improvement in the PTENS group via VAS (p=0.05 and 0.04).
  • No significant differences were observed in urinary incontinence, frequency, or constipation between groups.

Conclusions:

  • Single weekly sessions of PTENS are effective for treating pediatric OAB symptoms, specifically urgency and enuresis.
  • The treatment also improved caregiver-reported outcomes.
  • Larger studies are recommended to confirm these findings.
Abstract